Warning: mkdir(): Permission denied in /home/virtual/lib/view_data.php on line 81
Warning: fopen(upload/ip_log/ip_log_2024-11.txt): failed to open stream: No such file or directory in /home/virtual/lib/view_data.php on line 83
Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 84 A relapsed case of imported tertian malaria after a standard course of hydroxychloroquine and primaquine therapy
A relapsed case of imported tertian malaria after a standard course of hydroxychloroquine and primaquine therapy
K J Yi,*1M H Chung,1H S Kim,1C S Kim,1 and S H Pai2
1Department of Internal Medicine, Inha University, Medical College, Inchon 400-103, Korea.
Received October 31, 1997; Accepted March 12, 1998.
Abstract
Resistance of Plasmodium species to antimalarial agents has become increasingly challenging to the management and prevention of malaria. We experienced an imported case of tertian malaria due to Plasmodium vivax relapsed after a seemingly successful treatment with conventional course of hydroxychloroquine and primaquine. A 35-year-old man developed fever three days after return from India and mainland China. After his illness was diagnosed as tertian malaria, he was managed with hydroxychloroquine and then primaquine (primaquine base 15 mg/day for 14 days). Thereafter peripheral blood smears showed no malarial parasites, and there was no relapse of symptom until the 55th post-treatment day, however, six months after the above treatment tertian malaria relapsed. He was managed with the same medications again and malaria did not relapse for 10 months.
References
1.
National communicable disease report by month and area, 1997. 12. CDMR 1998;90:23.
2.
Baird JK, Basri H, Purnomo, Bangs MJ, Subianto B, Patchen LC, Hoffman SL. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg 1991;44(5):547–552.
3.
Bunnag D, Karbwang J, Thanavibul A, Chittamas S, Ratanapongse Y, Chalermrut K, Bangchang KN, Harinasuta T. High dose of primaquine in primaquine resistant vivax malaria. Trans R Soc Trop Med Hyg 1994;88(2):218–219.
4.
Coatney GR, et al. Primaquine and quinocide as curative agents against sporozoite-induced Chesson strain vivax malaria; a preliminary report. J Nat Malaria Soc 1962;9:285–292.
5.
Collins WE, Jeffery GM. Primaquine resistance in Plasmodium vivax. Am J Trop Med Hyg 1996;55(3):243–249.
6.
Kim JH, et al. Korean J Infect Dis 1997;29:503–507.
7.
Kimura M, et al. Kasenshogaku Zasshi 1996;70:1086–1091.
8.
Krotoski WA. Frequency of relapse and primaquine resistance in Southeast Asian vivax malaria. N Engl J Med 1980;303(10):587.
9.
Lee DY, et al. Korean J Int Med 1988;34:660–665.
10.
MOORE DV, LANIER JE. Observations on two Plasmodium falciparum infections with an abnormal response to chloroquine. Am J Trop Med Hyg 1961;10:5–9.
11.
Pukrittayakamee S, Vanijanonta S, Chantra A, Clemens R, White NJ. Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. J Infect Dis 1994;169(4):932–935.
12.
Smoak BL, DeFraites RF, Magill AJ, Kain KC, Wellde BT. Plasmodium vivax infections in U.S. Army troops: failure of primaquine to prevent relapse in studies from Somalia. Am J Trop Med Hyg 1997;56(2):231–234.
13.
Soh CT, et al. Yonsei Res Top Med 1985;16:11–18.
14.
WHO. Weekly epidemiological record 1996;71:25–32.
15.
WHO. Weekly epidemiological record 1996;72:285–292.
16.
Yim HW, et al. Korean J Infect Dis 1996;28:219–224.
PDF Links
Full text via DOI
Download Citation 
